Settlement Spotlight
Active Investigations
-
California Early Termination Fee (ETF) Class Action Lawsuit Investigation
-
Depakote Birth Defect Class Action Lawsuit Investigation
-
Dilantin Class Action Lawsuit Investigation
-
Drywall Price-Fixing, Antitrust Class Action Lawsuit Investigation
-
Kidney Dialysis Heart Attack, GranuFlo & NaturaLyte Recall Class Action Lawsuit Settlement Investigation
-
Mesothelioma Asbestos Class Action Lawsuit Settlement Investigation
-
Metal on Metal Replacement Hip Implant Class Action Lawsuit Investigation
-
Mirena IUD Injury Class Action Lawsuit Settlement Investigation
-
Propecia Loss of Sex Drive, Sexual Dysfunction Class Action Lawsuit Settlement Investigation
-
Stevens Johnson (SJS) & Toxic Epidermal Necrolysis (TEN) Class Action Lawsuit Investigation
-
Text Message Spam, Cell Phone Call TCPA Class Action Lawsuit Settlement Investigation
-
Type 2 Diabetes Drugs Januvia, Byetta Class Action Lawsuit Investigation
-
Unum/UnumProvident Disability Insurance Claim Denial Class Action Lawsuit Investigation
-
Vaginal Mesh Sling Class Action Lawsuit Investigation
-
Wage & Hour, Unpaid Overtime Class Action Lawsuit Investigation
-
Yaz/Yasmin, Ocella & Beyaz Birth Control Class Action Lawsuit Settlement Investigation
-
Zithromax Z-Pak Azithromycin Class Action Lawsuit Settlement Investigation
-
Zoloft & SSRI Antidepressant Birth Defect Class Action Lawsuit Investigation
Top Settlements
Top News
Top Drug Lawsuits
Class Action Lawsuit and Settlement News
| Kashi False Advertising Class Action Lawsuit Survives in Court |
|
|
- Thursday, 16 August 2012 11:50
Kashi False Advertising Class Action Lawsuit Survives in Court
By Mike Holter
A class action lawsuit alleging Kashi deceptively advertised its GoLean and TLC products as “all natural” has survived in court, allowing the Plaintiffs to pursue compensation for U.S. consumers who purchased “falsely labeled” Kashi products.The ruling comes nearly a year after the Kashi false advertising lawsuit was filed, which alleges Kashi’s act of printing “All Natural” or “Nothing Artificial” on its packages violates federal and California laws protecting consumers from false or misleading advertising. Plaintiffs in the class action lawsuit claim Kashi mislabeled their products as free of artificial ingredients, even though some of their GoLean and TLC products are "composed almost entirely of synthetic and unnaturally processed ingredients." Some of these synthetic ingredients are even listed by the FDA as prescription drugs and federally declared hazardous substances, the Kashi class action lawsuit says.
Kashi tried to dismiss the false advertising class action lawsuit in April 2012, asserting that its food labels are not false nor misleading, that the Plaintiff’s claims are preempted by federal law, and that the terms “All Natural” and “Nothing Artificial” are too subjective and vague to actionable.
U.S. District Judge Marilyn Huff last month dismissed several of the federal law claims and common law claims made in the Kashi class action lawsuit, but denied dismissal of the California Consumer Protection Law claims.
A copy of the original Kashi GoLean & TLC False Advertising Class Action Lawsuit can be read here.
The case is Michael Bates v. Kashi Company, Kellogg Company, et al., Case No. 11-cv-1967, U.S. District Court, Southern District of California.
Updated August 16th, 2012
All class action and lawsuit news updates are listed in the Lawsuit News section of Top Class Actions
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
Top Class Actions Legal Statement
©2008 - 2012 Top Class Actions® LLC
Various Trademarks held by their respective owners
Last Updated on Thursday, 27 December 2012 11:09




Comments
RSS feed for comments to this post